Schedule 13G ownership disclosure

Frazier Life Sciences Acquisition Corp. II

Class A Ordinary Shares, par value $0.0001 per share · CUSIP: G37103101

Event date: 2026-10-15

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Venrock Healthcare Capital Partners III, L.P.

    Shares: 700,000.00 · Class: 9.0%

  • VHCP Co-Investment Holdings III, LLC

    Shares: 700,000.00 · Class: 9.0%

  • Venrock Healthcare Capital Partners EG, L.P.

    Shares: 700,000.00 · Class: 9.0%

  • VHCP Management III, LLC

    Shares: 700,000.00 · Class: 9.0%

  • VHCP Management EG, LLC

    Shares: 700,000.00 · Class: 9.0%

  • Nimish Shah

    Shares: 700,000.00 · Class: 9.0%

  • Bong Y. Koh

    Shares: 700,000.00 · Class: 9.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001738048-26-000075
Form type
SCHEDULE 13G
Filer
Frazier Life Sciences Acquisition Corp. II
CIK
CIK 2153598
Filed
Oct 27, 2026
Reporting period
Oct 15, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub